In the short-term, the firm is looking to enter markets close to home—including Taiwan, Macau, Singapore, Hong Kong and Saudi Arabia.

Source: [Fortune](https://fortune.com/2026/10/26/japanese-biotech-firm-cancer-cure/)

Sponsored